CLINICAL_TRIALS ClinicalTrials.gov record update

A Phase IV, Single-Centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2012/2013 Formulation of the Enzira® Vaccine in Two Groups of Healthy Volunteers: 'Adults' (Aged 18 to 59 Years) and 'Older Adults' (Aged 60 Years or Older)

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Record identity and dates

Source: ClinicalTrials.gov
Source record ID: NCT01591837
Title field or adapter rule: protocolSection.identificationModule.officialTitle
Ingested At: 2026-04-28T10:36:53.378036+00:00
Published At: 2013-11-18T00:00:00+00:00
Record Updated At: 2018-06-27
Results Posted At: 2013-11-18
Timestamp Basis: source retrieval time was not retained by the feed adapter
Date limitation: source retrieval time was not retained by the feed adapter

protocolSection.conditionsModule.conditions: ["Influenza, Human"]
protocolSection.statusModule.lastUpdatePostDateStruct.date: "2018-06-27"
protocolSection.identificationModule.nctId: "NCT01591837"
protocolSection.identificationModule.officialTitle: "A Phase IV, Single-Centre, Open-label Study to Evaluate the Immunogenicity and Safety of the 2012/2013 Formulation of the Enzira\u00ae Vaccine in Two Groups of Healthy Volunteers: \u0027Adults\u0027 (Aged 18 to 59 Years) and \u0027Older Adults\u0027 (Aged 60 Years or Older)"
protocolSection.statusModule.overallStatus: "COMPLETED"
protocolSection.designModule.phases: ["PHASE4"]
protocolSection.statusModule.resultsFirstPostDateStruct.date: "2013-11-18"

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.